| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 138391-28-3 | | elav protein | | | | |
| 138391-29-4 | | ccg1 protein | | | | |
| 138391-32-9 | | arnt protein | | | | |
| 138391-53-4 | | activin receptor | | | | |
| 1383918-40-8 | n2-[(9h-芴-9-基甲氧基)羰基]-n6-(1-硫代十四烷基)-l-赖氨酸 | n2-[(9h-fluoren-9-ylmethoxy)carbonyl]-n6-(1-thioxotetradecyl)-l-lysine | | | | |
| 1383925-31-2 | | 5',5''-bis(4-carboxyphenyl)-[1,1':3',1'':3'',1'''-quaterphen | | | | |
| 1383927-19-2 | | ethyl 4-(4-chloro-1h-pyrazolo[3,4-d]pyrimidin-1-yl)benzoate | | | | |
| 1383968-85-1 | | tert-butyl 4-((2-amino-4-bromophenyl)amino)piperidine-1-carboxylate | | | | |
| 1383976-40-6 | | 4-chloro-5-fluoro-6-methoxy-2-methylpyrimidine | | | | |
| 1383976-62-2 | | 4-fluoro-2-methylindoline | | | | |
| 138398-61-5 | | diabetes associated peptide amide*fragment 8-37 r | C140H227N43O43 | 3200.60 | | |
| 1383985-12-3 | | 4-bromo-2-(prop-1-yn-1-yl)pyridine | | | | |
| 1383985-27-0 | | 3-chloro-2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | | | | |
| 13840-04-5 | | sulfuric acid, ammonium cerium salt | | | | |
| 13840-33-0 | 次氯酸锂 | Hypochlorous acid, lithium salt | ClO·Li | 58.39 | | |
| 13840-55-6 | | boric acid (h3bo3), calcium salt | | | | |
| 13840-56-7 | 硼酸钠 | boric acid (h3bo3), sodium salt | BH3O3·xNa | | | |
| 13840-88-5 | | Boron dioxide | BO2 | 42.81 | | |
| 138401-24-8 | 2-丁基-3-[[2'-氰基-[1,1'-联苯]-4-基]甲基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮 | 2-butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one | | | | |
| 138402-05-8 | 2-丁基-1,3-二氮杂螺[4.4]非2-烯-4-酮 | 2-butyl-1,3-diazaspiro[4.4]non-2-en-4-one | | | | |
| 138402-11-6 | 伊贝沙坦 | irbesartan | C25H28N6O | | | |
| 138402-13-8 | 4-(cbz-氨基)四氢吡喃-4-甲酸 | 4-(cbz-amino)tetrahydropyran-4-carboxylic acid | | | | |
| 138402-33-2 | 缬沙坦杂质46 | valsartan impurity 46 | | | | |
| 138402-36-5 | 3-(氨甲基)-5-氯吡啶 | 3-(aminomethyl)-5-chloropyridine | | | | |
| 138404-38-3 | (2-亚氨基-1,3-噻唑烷-3-基)乙酸氢甲酯(氢溴酸甲酯) | methyl (2-imino-1,3-thiazolidin-3-yl)acetate hydrobromide | | | | |
| 138404-84-9 | | n,n'-(2-hydroxy-1,3-propanediyl)bis-hexadecanamid | | | | |
| 138404-87-2 | | n,n'-(2-hydroxy-1,3-propanediyl)bis-benzenepropanamid | | | | |
| 138404-89-4 | | n,n'-(2-hydroxy-1,3-propanediyl)bis-cyclohexanepropanamid | | | | |
| 138404-91-8 | | tricyclo(3.3.1.1(sup 3,7))decane-1-carboxamide, n,n'-(2-hydroxy-1,3-propanediyl | | | | |
| 138404-98-5 | | n-((phenylmethoxy)carbonyl)-glycin 2-((1-oxodecyl)amino)-1-(((1-oxodecyl)am | | | | |
| 138404-99-6 | | n-((phenylmethoxy)carbonyl)-glycin 2-((1-oxohexadecyl)amino)-1-(((1-oxohexa | | | | |
| 138405-00-2 | | n-((phenylmethoxy)carbonyl)-glycin 2-((1-oxo-3-phenylpropyl)amino)-1-(((1-o | | | | |
| 138405-01-3 | | n-((phenylmethoxy)carbonyl)-glycin 2-((3-cyclohexyl-1-oxopropyl)amino)-1-(( | | | | |
| 138405-02-4 | | glycine, n-((phenylmethoxy)carbonyl)-, 2-((tricyclo(3.3.1.1(sup 3,7))dec-1-ylca | | | | |
| 138405-05-7 | 2,3-二甲基(2R,3R)-rel-1,2,3,4-丁烷四羧酸酯 | 2,3-dimethyl (2R,3R)-rel-1,2,3,4-butanetetracarboxylate | | | | |
| 1384080-45-8 | | tert-butyl n-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]carbamate | | | | |
| 1384081-81-5 | | 4-fluoro-3,3-dimethylindoline | | | | |
| 13841-66-2 | | isonicotinic acid butyl ester | C10H13NO2 | 179.22 | | |
| 13841-78-6 | | Rhenate(2-),octachlorodi-(Re-Re),dipotassium | Cl8H2K2ORe2 | 752.25 | | |
| 13841-81-1 | | Cobaltate(1-),trifluoro-,potassium | CoF3K | 155.03 | | |
| 13841-96-8 | | diammine-diiodoplatin | | | | |
| 1384100-95-1 | | 4-(tert-butyl)-1h-imidazol-2-amine hcl | | | | |
| 1384101-98-7 | | boc-7-fluoro-d-tryptophan | | | | |
| 1384101-99-8 | | boc-7-bromo-d-tryptophan | | | | |
| 1384102-00-4 | | boc-7-fluoro-l-tryptophan | | | | |
| 1384122-86-4 | n-[(4-甲氧基苄基)氧基]-2-硝基苯磺酰胺 | n-[(4-methoxybenzyl)oxy]-2-nitrobenzenesulfonamide | | | | |
| 138413-77-1 | | vp7 antigen, horsesickness disease virus serotype 4 | | | | |
| 138414-68-3 | | flii protein | | | | |
| 138415-19-7 | | lef-1 protein | | | | |
| 138415-20-0 | | itr1 protein | | | | |
m.cnreagent.com